Hyperthyroidism
68
5
7
35
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.5%
1 terminated out of 68 trials
97.2%
+10.7% vs benchmark
9%
6 trials in Phase 3/4
6%
2 of 35 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 35 completed trials
Clinical Trials (68)
Natural History of Thyroid Function Disorders
Development of a Non-Invasive Prognostic Test for Graves Orbitopathy
Virtual Reality on Stress, Pain Levels in Patients With Hyperthyroidism Undergoing Biopsy
A Brief Video Intervention to Improve Patient Outcomes Following Radioiodine Treatment
Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter
The Sequestration of Holistic Stress Management Techniques for Adults
Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease
Superficial Cervical Plexus Block With Dexmedetomidine Versus Without Adjuvant in Thyroid Surgery
Prospective, Observational Study on the Carotid Intima-media Thickness in Patients Undergoing Thyroid Surgery
Pressure-enabled Retrograde Occlusive Therapy With Embolization for Control of Thyroid Disease (PROTECT Registry): A Multicenter Registry
Optimization With a Gamma Camera of the Individualized Patient Dosimetry in Radioiodine Therapy of Thyroid Diseases
Assessment of THL and Potential Risk of Hypothyroidism in Healthcare Workers Exposed to Low-dose Ionizing Radiation
Hyperthyroidism: Methimazole Plus L-carnitine and Selenium
Calcium+Calcitriol Versus PTH for the Prevention of Hypocalcemia in Thyroidectomy. Randomized Clinical Trial
Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft
Quest to Analyze One Thousand Humans Meditating
Evaluation of Renal Function in Patients With Hyperthyroidism
A Clinical Study of Hyperthyroidism in Children
Iodine Supplementation in Graves' Hyperthyroidism
Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone Stabilization